AVS, Now Part of Stryker, Enrolls First Patient in First-in-Human Coronary Intravascular Lithotripsy Study

Amplitude Vascular Systems (AVS), a medical device company recently acquired by Stryker and focused on treating severely ...

FRACTURE IDE trial of the Boston Scientific SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter meets primary safety and effectiveness endpoints

Boston Scientific Corporation (NYSE: BSX) today announced positive results from the pivotal FRACTURE Investigational Device ...
TCTMD

DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions

(UPDATED) Coronary intravascular lithotripsy shows promise for improving the ability to optimize PCI in severely calcified lesions, with good safety and efficacy out to 30 days, according to data from ...
TCTMD

Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year

(UPDATED) In stable CAD patients, using intravascular lithotripsy to break up superficial or deep calcium and pave the way for stent implantation results in good outcomes to 1 year, with low rates of ...

Boston Scientific’s SEISMIQ 4CE succeeds in trial for coronary artery disease

Boston Scientific (BSX) announced on Tuesday that its SEISMIQ 4CE catheter, an intravascular lithotripsy device designed to ...
Medical Device Network on MSN

Cagent Vascular raises $41M for dual-modality IVL platform advancement

Cagent will use the funds to complete a pivotal trial of its Serranator SONIC IVL system and support commercial necessitates ...
Morningstar

AVS, Now Part of Stryker, Enrolls First Patient in First-in-Human Coronary Intravascular Lithotripsy Study

POWER CAD I study will evaluate feasibility of the Pulse IVL™ system in patients with severely calcified coronary arterial disease Amplitude Vascular Systems (AVS), a medical device company recently ...